>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
1,6-二磷酸果糖钙盐狗急性毒性和长期毒性研究
作者:唐萌1 应汉杰2 谈伟君1 王习霞2 张文举1 欧阳平凯2 李纯德1 滕蔓1 虞秀珍1 
单位:1.东南大学公共卫生学院,江苏南京,210009; 2.南京工业大学,江苏南京,210009
关键词:1 6-二磷酸果糖钙盐 急性毒性 长期毒性 安全性评价  
分类号:R99
出版年·卷·期(页码):2002·21·第一期(109-114)
摘要:

目的:探讨1,6-二磷酸果糖钙盐(FDP-Ca2)单次或多次给药后动物出现的毒性反应及其性质和程度,寻找主要的靶器官、无毒反应剂量及药物的安全范围,以推断人的临床用量.方法:按照新药临床前安全性评价的要求进行狗急性毒性和长期毒性研究.结果:狗经口急性毒性试验各剂量组未见明显中毒症状,各剂量组化验检查指标也未见明显异常;长期毒性试验以1500mg*kg-1给药12周,狗的血肌酐值与对照组比较差异有显著性(P<0.05),其它未见明显异常,恢复期后实验组与对照组各项指标比较差异均无显著性(P>0.05).结论:FDP-Ca2临床治疗量为25~50mg*kg-1*d-1,仅为狗急性毒性试验安全量的1/200,500mg*kg-1为FDP-Ca2狗长期毒性试验的无毒反应剂量,此剂量为临床实际用量的10~20倍,因而推断FDP-Ca2在临床长期口服(治疗量为25~50mg*kg-1*d-1)是安全的.

Objective  The purpose of the experiment was to probe into the animal’s toxicity reaction,its nature and degree after receiving calcium fructose-1,6-diphosphate(FDP?Ca  2) once or repeatedly,look for the main target organ,nonpoisonous response dosage and safety range of the drug,and infer a clinical safety dosage.Methods  The experiment was conducted according to the preclinical safety evaluation for new drugs.Results   No obvious signs of toxicity and abnormality of laboratory parameters were found in all tested groups for acute toxicity experiment   per os  .In the long  term toxicity experiment,the creatinine levels were significantly higher in 1?500?mg·kg    -1   group at week 12,than those of control group(  P  &lt;0.05).No significant difference in regard to the indexes studied was found between the experimental and control groups after recovery.Conclusions  At present,the treatment dosage of FDP?Ca  2 is 25~50?mg·kg    -1  ·d    -1   body weight,which amounts to 1/200 of the safety dosage in acute toxicity,and nonpoisonous response dosage for long  term toxicity experiment.We may ,therefore,reasona~bly conclude that it is safe to take FDP?Ca  2 orally over a long period of time at the dose of 25~50?mg·kg    -1  ·d    -1  .

参考文献:

[1] Gregory G A, YU A C, CHAN P H. Fructose-1,6 diphosphate protects astrocytes from hypoxic damage, 1989
[2] OPIN L H. ATP synthesis and breakdoum,adenosine and response to ischemia, 1991
[3] 袁伯俊. 新药临床前毒性评价的有关问题, 1993
[4] 秦伯益. 新药评价概论, 1989
[5] 王治乔. 新药临床前安全性评价与实践, 1997
[6] ROWAN A N, GOLDBERG A M. Perspectives on alternatives to current anial testing techniques in preclinical toxicology. 1985. doi:10.1146/annurev.pa.25.040185.001301
[7] LITTLEFIELD N A, WOLFF G L, NELSON C J. Influence of genetic composition of test-animal populations on chronic toxicity studies used for risk estimation. 1985(6). doi:10.1080/15287398509530795
[8] Bailey K. Physiological factors affecting drug toxicity. 1983(4). doi:10.1016/0273-2300(83)90009-0 

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 411583 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364